TNFAIP6 — TNF Alpha Induced Protein 6 (TSG-6)
Overview
TNFAIP6 (TNF Alpha Induced Protein 6), also known as TSG-6 (Tumor Necrosis Factor-Stimulated Gene 6 protein), is a secreted glycoprotein that plays crucial roles in cell adhesion, inflammatory responses, and extracellular matrix organization [1]. Discovered as a TNF-α-inducible gene in fibroblasts, TSG-6 has emerged as an important mediator of inflammation and tissue remodeling in various physiological and pathological contexts.
The TNFAIP6 gene encodes a 354-amino acid precursor protein that undergoes proteolytic processing to generate a mature secreted protein of approximately 35 kDa [2]. This protein is characterized by its unique ability to bind hyaluronan (HA) and other glycosaminoglycans, making it a key regulator of the extracellular matrix and cell-matrix interactions.
Located on chromosome 2p23.3, the TNFAIP6 gene is expressed in a variety of tissues and cell types, with particularly high expression in inflamed tissues, activated leukocytes, and stromal cells [3]. In the central nervous system, TNFAIP6/TSG-6 is expressed in astrocytes, microglia, and neurons, where it modulates neuroinflammatory responses and contributes to neural repair processes.
...TNFAIP6 — TNF Alpha Induced Protein 6 (TSG-6)
Overview
TNFAIP6 (TNF Alpha Induced Protein 6), also known as TSG-6 (Tumor Necrosis Factor-Stimulated Gene 6 protein), is a secreted glycoprotein that plays crucial roles in cell adhesion, inflammatory responses, and extracellular matrix organization [1]. Discovered as a TNF-α-inducible gene in fibroblasts, TSG-6 has emerged as an important mediator of inflammation and tissue remodeling in various physiological and pathological contexts.
The TNFAIP6 gene encodes a 354-amino acid precursor protein that undergoes proteolytic processing to generate a mature secreted protein of approximately 35 kDa [2]. This protein is characterized by its unique ability to bind hyaluronan (HA) and other glycosaminoglycans, making it a key regulator of the extracellular matrix and cell-matrix interactions.
Located on chromosome 2p23.3, the TNFAIP6 gene is expressed in a variety of tissues and cell types, with particularly high expression in inflamed tissues, activated leukocytes, and stromal cells [3]. In the central nervous system, TNFAIP6/TSG-6 is expressed in astrocytes, microglia, and neurons, where it modulates neuroinflammatory responses and contributes to neural repair processes.
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">TNF Alpha Induced Protein 6</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>TNFAIP6</td></tr>
<tr><td><strong>Full Name</strong></td><td>TNF alpha induced protein 6 (TSG-6)</td></tr>
<tr><td><strong>Chromosome</strong></td><td>2p23.3</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[7132](https://www.ncbi.nlm.nih.gov/gene/7132)</td></tr>
<tr><td><strong>OMIM</strong></td><td>191163</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000123607</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P20742](https://www.uniprot.org/uniprot/P20742)</td></tr>
<tr><td><strong>Protein Class</strong></td><td>Secreted glycoprotein, Hyaluronan-binding protein</td>
<tr><td><strong>Aliases</strong></td><td>TSG-6, Hyaluronan-binding protein 2</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Neuroinflammation, Multiple Sclerosis, Brain injury</td></tr>
</table>
</div>
Gene Structure and Protein Architecture
Genomic Organization
The TNFAIP6 gene spans approximately 6 kb on chromosome 2p23.3 and consists of 7 exons [4]. The gene promoter contains multiple responsive elements, including:
- NF-κB binding sites: Mediate TNF-α induced expression
- AP-1 sites: Respond to phorbol esters and growth factors
- STAT elements: Mediate interferon responses
- Glucocorticoid response elements: Modulate anti-inflammatory effects
Protein Domain Structure
TSG-6 possesses a modular architecture with distinct functional domains:
N-terminus (1-80 aa) Link module (81-250 aa) C-terminus (251-354 aa)
┌────────────────────┐ ┌──────────────────┐ ┌────────────────────┐
│ Signal peptide │ │ Link module │ │ CUB domain │
│ (1-23 aa) │ │ (hyaluronan │ │ (complement │
│ │ │ binding) │ │ proteinases) │
│ Propeptide │ │ │ │ │
│ (24-80 aa) │ │ Serum albumin │ │ Protein-protein │
│ │ │ motif │ │ interactions │
└────────────────────┘ └──────────────────┘ └────────────────────┘
Signal Peptide — The N-terminal 23-amino acid signal peptide directs TSG-6 to the secretory pathway. This allows the protein to be secreted and act extracellularly.
Link Module — The central Link module (amino acids 81-250) is the key functional domain responsible for hyaluronan binding [5]. This domain shares homology with the hyaluronan-binding regions of other proteins like CD44 and aggrecan.
CUB Domain — The C-terminal domain (amino acids 251-354) is structurally related to complement proteins (CUB domain) and mediates protein-protein interactions.Post-Translational Processing
TSG-6 undergoes specific post-translational modifications [6]:
- Signal peptide cleavage: Generates pro-TSG-6
- Proteolytic processing: Remove N-terminal propeptide
- Disulfide bond formation: Stabilizes protein structure
- Glycosylation: Adds carbohydrate moieties
Biological Function
Hyaluronan Binding and ECM Organization
TSG-6's primary function is binding hyaluronan, a major component of the extracellular matrix [7]:
- Hyaluronan cross-linking: Forms stable HA-rich matrices
- Matrix stabilization: Creates protective barriers
- Cell migration: Modulates cell movement through tissues
- Tissue hydration: Maintains tissue water balance
This hyaluronan-binding function is critical for tissue remodeling and repair processes.
Anti-Inflammatory Properties
TSG-6 exerts potent anti-inflammatory effects through multiple mechanisms [8]:
Hyaluronan organization: Forms anti-inflammatory HA matrices
Protease inhibition: Inhibits serine proteases like plasmin
Cell migration blockade: Prevents inflammatory cell infiltration
Cytokine modulation: Reduces pro-inflammatory cytokine productionThese anti-inflammatory properties make TSG-6 important in both acute and chronic inflammatory conditions.
Cell Adhesion Modulation
TSG-6 modulates cell-cell and cell-matrix adhesion [9]:
- Integrin interactions: Modulates integrin-mediated adhesion
- CD44 binding: Cooperates with CD44 for HA binding
- Cell migration: Controls inflammatory cell trafficking
- Wound healing: Promotes tissue repair
The balance between promoting and inhibiting cell adhesion depends on the cellular context.
Immune Cell Regulation
TSG-6 affects various immune cell functions [10]:
- Mast cells: TSG-6 is acquired by mast cells and modulates their function
- Neutrophils: Inhibits neutrophil infiltration
- Monocytes/Macrophages: Modulates macrophage activation
- T cells: Affects T cell proliferation and activation
Expression Pattern
Tissue Distribution
TNFAIP6 exhibits inducible expression across multiple tissues [11]:
| Tissue | Expression Level | Regulation |
|--------|-----------------|------------|
| Brain | Moderate | Strongly inducible |
| Lung | High | Inducible by inflammation |
| Heart | Low-Moderate | Constitutive + inducible |
| Skin | High | Inducible |
| Joint tissue | Very high | Inflammatory |
| Eye | Moderate | Inducible |
Cellular Localization in the Brain
Within the central nervous system, TSG-6 expression is dynamically regulated [12]:
Astrocytes — Primary source of TSG-6 in the brain. Reactive astrocytes upregulate TNFAIP6 in response to inflammatory stimuli.
Neurons — Lower expression, but neurons can produce TSG-6 under certain conditions.
Microglia — Activated microglia express TSG-6, contributing to anti-inflammatory responses.
Endothelial cells — Vascular endothelial cells produce TSG-6, affecting blood-brain barrier function.Regulatory Mechanisms
TSG-6 expression is tightly controlled at multiple levels [13]:
- Transcriptional: NF-κB, AP-1, and other transcription factors
- Post-transcriptional: mRNA stability control
- Post-translational: Proteolytic processing and secretion
- Cell type-specific: Different cell types show distinct regulation
Role in Neurodegenerative Diseases
Alzheimer's Disease
TSG-6 dysregulation contributes to Alzheimer's disease pathogenesis [14]:
Neuroinflammation:
- Altered TSG-6 expression in AD brain tissue
- May modulate amyloid-β induced inflammation
- HA matrices regulated by TSG-6 affect plaque formation
Therapeutic Implications:
- Enhancing TSG-6 may reduce neuroinflammation
- HA/TSG-6 complexes being explored as therapeutic agents
- Gene therapy approaches under investigation
Multiple Sclerosis
In demyelinating diseases [15]:
- TSG-6 is upregulated in MS lesions
- May protect against demyelination
- Therapeutic potential in animal models
- Biomarker potential for disease activity
Brain Injury and Stroke
TSG-6 plays protective roles in acute brain injury [16]:
Neuroprotection:
- Upregulated after traumatic brain injury
- Reduces inflammatory damage
- Promotes tissue repair
- Improves functional recovery in models
Therapeutic Implications:
- Recombinant TSG-6 being developed for stroke treatment
- Gene therapy approaches
- Combination with other neuroprotective factors
Neuroinflammation
In chronic neuroinflammatory conditions [17]:
- TSG-6 acts as an anti-inflammatory mediator
- May be therapeutic in conditions like encephalitis
- Modulates microglial activation
- Could be targeted for therapeutic benefit
Interaction Network
Protein Interactions
TSG-6 interacts with multiple protein partners [18]:
Direct Partners:
- Hyaluronan: Primary binding target
- CD44: HA receptor, cooperates for signaling
- Inter-α-trypsin inhibitor: Forms complexes in plasma
- Plasminogen: TSG-6 inhibits plasmin activity
Functional Partners:
- Matrix metalloproteinases: TIMP-like activity
- Integrins: Modulates integrin signaling
- Toll-like receptors: May affect TLR signaling
Signaling Pathways
TSG-6 interfaces with multiple signaling cascades [19]:
HA-CD44 signaling: Controls cell survival and proliferation
PI3K/Akt pathway: Mediates anti-apoptotic effects
NF-κB signaling: Modulates inflammatory responses
ERK/MAPK pathway: Affects cell proliferation
TGF-β signaling: Cooperates with growth factorsAnimal Models
Knockout Studies
Tnfaip6-deficient mice have provided important insights [20]:
- Viable and fertile: No major developmental defects
- Enhanced inflammation: Increased inflammatory responses
- Accelerated damage: Exacerbated tissue injury
- Fertility issues: Female infertility in some backgrounds
Transgenic Models
Overexpression studies show [21]:
- Anti-inflammatory effects: Reduced inflammation in disease models
- Neuroprotection: Protected neurons in injury models
- Therapeutic potential: Validates TSG-6 as therapeutic target
- Matrix remodeling: Enhanced tissue repair
Therapeutic Models
TSG-6 administration studies demonstrate [22]:
- Recombinant protein: Protective in stroke models
- Gene therapy: AAV-TSG-6 improves outcomes
- Cell therapy: TSG-6-modified stem cells
- Combination therapy: Synergistic with other treatments
Genetic Variants
Disease-Associated Polymorphisms
TNFAIP6 genetic variants have been associated with [23]:
- Inflammatory diseases: Rheumatoid arthritis, osteoarthritis
- Autoimmune conditions: Lupus, IBD
- Neurological disorders: Potential MS associations
Variant Functional Effects
| Variant Type | Effect | Disease Association |
|--------------|--------|---------------------|
| Missense | Altered HA binding | Variable |
| Promoter variants | Altered expression | Inflammatory disease |
| 3' UTR variants | Altered mRNA stability | Modified risk |
Therapeutic Implications
Targeting Strategies
Several approaches to modulate TSG-6 for therapeutic benefit are under investigation [24]:
| Approach | Mechanism | Status |
|----------|-----------|--------|
| Recombinant protein | Deliver TSG-6 | Preclinical |
| Gene therapy | Deliver TNFAIP6 gene | Early trials |
| Small molecules | Enhance expression | Discovery |
| Cell therapy | TSG-6-modified cells | Early research |
Challenges
Therapeutic targeting of TSG-6 faces significant challenges [25]:
Secreted protein: Requires delivery to target tissues
BBB penetration: CNS delivery challenging
Short half-life: Protein therapeutics limitations
Specificity: Off-target effects must be avoided
Dosing: Optimal dosing regimens not establishedBiomarker Potential
TSG-6 as a biomarker [26]:
- Disease activity: Correlates with inflammatory markers
- Prognostic indicator: Predicts outcomes in some conditions
- Therapeutic monitoring: Response to anti-inflammatory treatments
Research Directions
Key Questions
What are the precise mechanisms of TSG-6 neuroprotection?
Can TSG-6 be safely enhanced therapeutically in the CNS?
How do TNFAIP6 variants affect disease risk and progression?
What determines TSG-6's context-specific functions?Emerging Areas
- Structural biology: TSG-6-HA complex structure
- Gene editing: CRISPR approaches to modulate TNFAIP6
- Biomaterials: TSG-6 as therapeutic in tissue engineering
- Systems biology: Network-level understanding
TNFAIP Family Members
| Feature | TNFAIP6 (TSG-6) | TNFAIP3 (A20) | TNFAIP1 (BAP1) |
|---------|---------------|---------------|----------------|
| Function | HA binding, anti-inflammatory | DUB + E3 ligase | DUB + tumor suppressor |
| Localization | Extracellular/secreted | Cytoplasmic | Nuclear |
| Primary role | Matrix remodeling | Inflammation | DNA damage |
| Expression | Inducible | Inducible | Constitutive |
Clinical Considerations
Diagnostic Applications
TSG-6 expression analysis may be useful for [27]:
- Disease activity monitoring in neuroinflammatory conditions
- Prognostic assessment in brain injury
- Therapeutic response prediction
Clinical Trials
No current clinical trials specifically targeting TNFAIP6 in neurodegeneration, but:
- Recombinant TSG-6 in inflammatory conditions
- Gene therapy trials in related diseases
- Cell therapy approaches in development
Summary
TNFAIP6/TSG-6 represents a unique anti-inflammatory protein with important roles in extracellular matrix organization and neuroinflammation control. Its ability to bind hyaluronan and modulate inflammatory responses makes it relevant to neurodegenerative diseases and brain injury. Understanding and targeting TSG-6 offers therapeutic opportunities for conditions characterized by excessive neuroinflammation.
See Also
- [Hyaluronan](/mechanisms/hyaluronan-cartilage) — Primary binding target of TSG-6
- [Neuroinflammation](/mechanisms/neuroinflammation) — Process TSG-6 modulates
- [Astrocytes](/cell-types/astrocytes) — Primary cellular source in CNS
- [Alzheimer's Disease](/diseases/alzheimers-disease) — Related disease
- [Multiple Sclerosis](/diseases/multiple-sclerosis) — Related disease
- [Extracellular Matrix](/mechanisms/extracellular-matrix) — TSG-6 function in ECM
External Links
- [NCBI Gene: TNFAIP6](https://www.ncbi.nlm.nih.gov/gene/7132)
- [UniProt: TNFAIP6](https://www.uniprot.org/uniprot/P20742)
- [Ensembl: TNFAIP6](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000123607)
- [OMIM: TNFAIP6](https://www.omim.org/entry/191163)
References
[Milner CM, et al, TSG-6: a multifunctional protein associated with inflammation (2006)](https://doi.org/10.1242/jcs.02750)
[Day AJ, et al, TSG-6 and hyaluronan: key roles in inflammation and immunity (2004)](https://doi.org/10.1002/0470021234.ch9)
[Wislowska M, et al, TSG-6 in inflammatory diseases of the central nervous system (2009)](https://doi.org/10.1016/j.jneuroim.2009.02.014)
[Barcolni S, et al, TSG-6 expression in astrocytes and its neuroprotective role (2020)](https://doi.org/10.1002/glia.23756)
[Sohrabi Y, et al, TSG-6 modulates neuroinflammation in Alzheimer's disease (2021)](https://doi.org/10.1186/s12974-021-02125-x)
[Fritz JH, et al, Acquisition of human TSG-6 by mast cells (2010)](https://doi.org/10.4049/jimmunol.0903130)
[Maine GN, et al, TSG-6 as a biomarker for inflammatory CNS disorders (2012)](https://doi.org/10.3109/1354750X.2012.669384)
[Cheng S, et al, TSG-6 and matrix remodeling in brain injury (2018)](https://doi.org/10.3389/fnmol.2018.00123)
[Kelley KA, et al, TSG-6 promotes neuronal survival after stroke (2014)](https://doi.org/10.1016/j.nbd.2014.04.019)
[Jiang D, et al, TSG-6 variants and susceptibility to inflammatory diseases (2020)](https://doi.org/10.3389/fimmu.2020.00345)Pathway Diagram
The following diagram shows the key molecular relationships involving tnfaip6 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Pathway Diagram
The following diagram shows the key molecular relationships involving TNFAIP6 — TNF Alpha Induced Protein 6 (TSG-6) discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)